U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07601516) titled 'Real World Effectiveness and Safety of Deutetrabenazine in Adult Chinese Patients With Huntington's Disease (HD) Chorea in China' on May 15.
Brief Summary: The Primary Objective: To evaluate the real-world effectiveness of deutetrabenazine in adult patients with chorea associated with Huntington's disease in China.
The Secondary Objectives: To evaluate the real-world safety of deutetrabenazine in adult patients with chorea associated with Huntington's disease in China.
Study Start Date: Feb. 02, 2024
Study Type: INTERVENTIONAL
Condition:
Huntington's Disease
Chorea
Intervention:
DRUG: Deutetrabenazine
deutetrabenazine tablets...